TempraMed Technologies Ltd. (CSE:VIVI)

Market Cap	23.30M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	77.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,000
Open	0.3100
Previous Close	n/a
Day's Range	0.3000 - 0.3100
52-Week Range	0.2700 - 1.4000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TempraMed Technologies

TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products. Its primary focus is storage and management of injectable for temperature-sensitive medications. The company provides VIVI Cap, an insulin insulation and travel case; VIVI Cap Smart, a connected insulin storage and protection; VIVI Med, a temperature medication; and VIVI Epi, a Storage and Protection for EpiPen. The company was incorporated in 2023 and is based in Burnaby, Canad...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: VIVI

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error